公开(公告)号：US20190137516A1

公开(公告)日：2019-05-09

申请号：US16239834

申请日：2019-01-04

Applicant: AJINOMOTO CO., INC.

Inventor： Takeshi Ikeuchi ,  Yuki Yano ,  Naoko Arashida ,  Rumi Nishimoto ,  Kazutaka Shimbo ,  Nobuhiro Kawai

IPC: G01N33/68 ,  G16H10/40 ,  G16H50/30

Abstract: An evaluating method includes an evaluating step of evaluating future risk of developing Alzheimer's disease for a subject to be evaluated having mild cognitive impairment using a concentration value of at least one of α-ABA, Ala, Arg, Asn, Cit, Gln, Glu, Gly, His, Ile, Leu, Lys, Met, Orn, Phe, Pro, Ser, Thr, Trp, Tyr, Val, Cysteine, Taurine, bABA, Ethylglycine, Hypotaurine, 3-Me-His, 5-HydroxyTrp, aAiBA, and N8-Acetylspermidine in blood of the subject.